News

Developed by BioAlliance Pharma, Loramyc is a mucoadhesive gingival tablet containing miconazole administered once-a-day over 7 to 14 days. Additionally, Therabel has made a fully dedicated team and

The decrease of $160,000 in revenue was due primarily to a decrease in Aphthasol product sales during the first quarter of 2011. ULURU has reported a net loss

Synexus has delivered the targeted number of patients within the agreed timelines. Synexus chief executive Christophe Berthoux said the Synexus model works particularly well with companies like Creabilis

MWV said its preservative-free pump solutions offer a five-fold mechanical protection system that assures germ-free pump dosing to the patient while providing shelf life similar to traditional formulations.

The company has reported a net income of $2.24m, or $0.08 per diluted share, compared to net income of $4.93m or $0.18 per diluted share, for the same

CPI-300 is a high strength of Bupropion Hydrochloride (HCl), the active ingredient in Wellbutrin XL. The company’s new submission addresses the two main issues identified by the FDA

VICTRELIS is a direct acting antiviral (DAA) agent that interferes with the ability of the hepatitis C virus to replicate by inhibiting a key viral enzyme (NS3/4A serine

Sinovac’s net loss was $3.66m for the first quarter 2011, or $0.05 loss per diluted share, compared to net loss of $1.21m, or $0.01 loss per diluted share,

Neurologix is a clinical-stage biotechnology company engaged in discovery, development and commercialization of life-altering gene transfer therapies for serious disorders of the brain and central nervous system. The